Literature DB >> 30843862

Eicosapentaenoic acid and aspirin for colorectal adenomas.

Nilay Danış1, Fatih Tekin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30843862      PMCID： PMC6408171          DOI： 10.5152/tjg.2019.280219

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  5 in total

1.  Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis.

Authors:  Nicholas J West; Susan K Clark; Robin K S Phillips; John M Hutchinson; Roger J Leicester; Andrea Belluzzi; Mark A Hull
Journal:  Gut       Date:  2010-03-26       Impact factor: 23.059

2.  Colorectal cancer: epidemiology, risk factors, and health services.

Authors:  Farin Amersi; Michelle Agustin; Clifford Y Ko
Journal:  Clin Colon Rectal Surg       Date:  2005-08

3.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

Review 4.  Colorectal cancer development and advances in screening.

Authors:  Karen Simon
Journal:  Clin Interv Aging       Date:  2016-07-19       Impact factor: 4.458

5.  Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.

Authors:  Mark A Hull; Kirsty Sprange; Trish Hepburn; Wei Tan; Aisha Shafayat; Colin J Rees; Gayle Clifford; Richard F Logan; Paul M Loadman; Elizabeth A Williams; Diane Whitham; Alan A Montgomery
Journal:  Lancet       Date:  2018-11-19       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.